JAMA Dermatology

<jats:p>This Viewpoint discusses different approaches to evaluating and managing melanoma in situ to help mitigate the potential harms of overdiagnosis.</jats:p>

The rapid rise in cutaneous melanoma diagnoses.

N Engl J Med

Melanoma overdiagnosis: why it matters and what can be done about it.

Br J Dermatol

Lived experiences and fear of cancer recurrence among survivors of localized cutaneous melanoma.

JAMA Dermatol

Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis classification schema for melanocytic lesions: a consensus statement.

JAMA Netw Open

Melanoma over-diagnosis: historical perspective and the path forward.

Dermatol Pract Concept

Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial.

A randomised, controlled, multicentre trial of imiquimod versus radiotherapy for lentigo maligna.

J Clin Oncol

This Viewpoint discusses different approaches to evaluating and managing melanoma in situ to help mitigate the potential harms of overdiagnosis.

Navigating Melanoma In Situ in the Age of Overdiagnosis.

Navigating Melanoma In Situ in the Age of Overdiagnosis

Navigating Melanoma In Situ in the Age of Overdiagnosis

Clinical Summary

What was studied

Study limitations

Related Questions